John Trainer - 04 Apr 2023 Form 4 Insider Report for NexImmune, Inc.

Reporting relationship: Chief Financial Officer
Issuer ticker: N/A
Reported as of: 04 Apr 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Apr 2023, 20:41:13 UTC
Prior SEC filing: 25 Nov 2022
Source filing: View source filing
Reporting owner signature: /s/ John Rudy, attorney-in-fact

Key filing fact

John Trainer filed Form 4 for NexImmune, Inc. on 06 Apr 2023.

Key facts

This page summarizes John Trainer's Form 4 filing for NexImmune, Inc..
10 reported transactions and 10 derivative rows are listed below.
Accepted by SEC: 06 Apr 2023, 20:41.

Change

Previous filing in this sequence was filed on 25 Nov 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEXI transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +89,100
Change %
Price: $0.000000
Shares after: 89,100
Date: 04 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 89,100
Exercise price: $0.4100
Footnotes: F1

NEXI transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -78,100
Change %: -100%
Price
Shares after: 0
Date: 04 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 78,100
Exercise price: $4.22
Footnotes: F2

NEXI transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +27,660
Change %
Price
Shares after: 27,660
Date: 04 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 27,660
Exercise price: $1.23
Footnotes: F2

NEXI transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +50,440
Change %
Price
Shares after: 50,440
Date: 04 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,440
Exercise price: $0.8200
Footnotes: F2

NEXI transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -28,987
Change %: -100%
Price
Shares after: 0
Date: 04 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 28,987
Exercise price: $17.00
Footnotes: F3

NEXI transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +18,720
Change %
Price
Shares after: 18,720
Date: 04 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,720
Exercise price: $1.23
Footnotes: F3

NEXI transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +10,267
Change %
Price
Shares after: 10,267
Date: 04 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,267
Exercise price: $0.8200
Footnotes: F3

NEXI transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -102,949
Change %: -100%
Price
Shares after: 0
Date: 04 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 102,949
Exercise price: $5.17
Footnotes: F4

NEXI transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +89,222
Change %
Price
Shares after: 89,222
Date: 04 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 89,222
Exercise price: $1.23
Footnotes: F4

NEXI transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +13,727
Change %
Price
Shares after: 13,727
Date: 04 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,727
Exercise price: $0.8200
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

25% of this option shall vest and become exercisable on April 4, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Trainer's continued service to the corporation on each vesting date.

Footnote F2

The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on April 5, 2022, of which 19,525 shares vested, and the remainder of the options will vest in equal monthly installments such that on April 5, 2026, all shares subject to the option shall be vested, subject to Mr. Trainer's continued service on each vesting date.

Footnote F3

The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which 28,987 shares vested, and the remainder of the options will vest in equal monthly installments such that on February 11, 2025, all shares subject to the option shall be vested, subject to Mr. Trainer's continued service on each vesting date.

Footnote F4

The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 5, 2020, of which 130,401 shares vested, and the remainder of the options will vest in equal monthly installments such that on January 8, 2024, all shares subject to the option shall be vested, subject to Mr. Trainer's continued service on each vesting date. Mr. Trainer has exercised his right to purchase an aggregate of 61,769 shares subject to the original option.